Pharmacy Podcast Network

phactMI, a 501 (c)(6) corporation, is a collaboration of Medical Information leaders from the pharmaceutical industry. These Medical Information professionals provide accurate and unbiased clinical data on their products that facilitates the safe and effective use of medicines. How and why was phactMI created? Join us in this episode as Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers, The State University of New Jersey and guest speakers Patrick Reilly, PA, CEO, phactMI and Mary Sendi, North America Medical Information Regional Lead Pfizer/ President phactMI discuss medical information, the role of manufacturers in providing scientifically accurate information, and the genesis of phactMI. Learn more about phactMI at www.phactMI.org/about/ Follow phactMI on LinkedIn, Facebook, and Twitter References: phactMI. About phactMI. www.phactMI.org/about. Accessed November 10, 2021. Hermes-DeSantis ER, Johnson RM, Redlich A, et al. Proposed best practice guidelines for scientific response documents: a consensus statement from phactMI. Ther Innov Regul Sci. 2020;54:1303-11. Rai R, Hermes-DeSantis ER, phactMI. Healthcare professional’s opinions on an endorsement tool for scientific response documents developed by pharmaceutical companies. phactMI Internal Data. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting. 2019. phactMI. Code of practice. www.phactMI.org/code-of-practice. Accessed November 10, 2021. Learn more about your ad choices. Visit megaphone.fm/adchoices

What does public health mean to you? Access to healthcare for all walks of life Bio  Dr John Brosious is the founder of the gender surgery program at UNLV, and co-founder of NGAHP. After graduating from Indiana University School of Medicine, he completed his plastic surgery residency at the University of Nevada. His passion in gender affirming care began years ago while in practice in Pittsburgh, Pennsylvania. After returning to Nevada in 2016, he quickly realized the need to streamline gender-affirming healthcare in Nevada. Working with the gender expansive community is currently the focus of his practice, in addition to complex reconstruction for trauma, burn, and cancer patients. His hobbies include fitness, traveling, and tattoos. Link: https://www.unlv.edu/people/john-brosious Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of DarshanTalks Podcast where host Darshan Kulkarni Pharm.D, MS, Esq. welcomes guest Michael A. Swit, Esq. to discuss Medical Affairs Compliance. Michael A. Swit is a long-time FDA regulatory Attorney and Chief Regulatory Counsel at Varian Medical Systems. He has taught and written on an array of subjects relating to FDA regulation and related commercial activities, including directing courses on FDA regulation of drug/device advertising and on generic drug approvals. A former member of the Food & Drug Law Journal Editorial Board, Mr. Swit has spoken frequently at conferences sponsored by such organizations as RAPS, FDLI, and DIA. Swit is a highly experienced food & drug law attorney who has addressed critical FDA legal issues since 1984. His vast experience includes serving as general counsel and secretary of Par Pharmaceutical, a prominent generic drug company, and, thus, he brings a commercial perspective to his work. His private practice has included stints in the FDA Law Practice Groups in the San Diego offices of both Duane Morris and Heller Ehrman, and at McKenna & Cuneo (now Dentons), in the firm's D.C. and San Diego offices. He also served for seven years as Vice President at The Weinberg Group, a premier FDA regulatory consulting firm, and as the CEO of FDAnews.com, a premier publisher of FDA newsletters and other information products. In the initial part of the podcast, he described how to do the Varian Company functions and its role in medical affairs. At Varian, he spearheads the resolution of all legal issues impacting the regulatory, quality, and clinical challenges of the world's leading developer of radiation treatment technologies used to treat cancer and other conditions, including overseeing the firm's promotional review process. The company's aim is 'creating a world without the fear of cancer'. He mentioned every company makes mistakes or sometimes customers think that the company has done something wrong and every sphere will have a problem that is unavoidable but how to respond and the key element to tackle those circumstances that determines everything. He works in the compliance department resolving disputes and problems. The mid-segment was about the work processes and balance, then he was asked about the SOPs in medical affairs i.e. standard operating procedures for clinical practice, he had prime approaches for the same - policies, SOPs, granular work construction, and it ought to be automation. He also mentioned mnemonic words that are important in this sphere. The conversation also included The Chicago Tylenol scandal ( these were a series of poisoning deaths resulting from drug tampering in the Chicago metropolitan area in 1982) concerning crisis management and how one can do a right recall. Lastly, they touched upon the influencer marketing aspect. Connect with Michael A. Swit: https://www.linkedin.com/in/michaelswit/ Connect with us: Website: http://www.darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Twitter: https://twitter.com/darshantalks ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice. 5. This does not create an attorney-client relationship. Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the inaugural episode of the Integra X Files! Join our hosts Frances Nahas and Jim McDonald in a conversation with guest Chad Worz, Pharm.D., BCGP, FASCP, the chief executive officer of ASCP, as they talk long-term care pharmacy trends, stormtroopers, and highlights from the recent ASCP Annual Meeting. For all the X-Files Episodes, visit the Integra X-Files Learn more about your ad choices. Visit megaphone.fm/adchoices

Lindsey Childs-Kean, PharmD, MPH, BCPS, co-founder and advisory team member of the #PharmGradWishList interviews Joseph Washington, PharmD/MPH candidate, #PGWL sponsee and winner of the 2021 PGWL Post-Graduate Education Scholarship to support the financial endeavors involved with pursuing graduate pharmacy training. Joseph is a soon to be graduate of the University of Florida, pursuing a dual degree in pharmacy along with a Master of Public Health, and is fervently paving a way to make his mark in the distinguished profession of clinical sciences. Joseph has a drive to holistically change the landscape of healthcare, to provide equitable access to services amongst all populations. More so, Joseph has had the distinction of serving as the National President for the Student National Pharmaceutical Association, where he routinely amplified the voices of underrepresented minorities. Now, Joseph is looking to begin his career, building off of his clinical prowess, within the realm of health economics and outcomes research. Joseph is appreciative of the outpouring of support from the pharmacy community, who have devoted efforts to allow young clinicians, such as himself, the opportunity to continue to break down barriers and hurdles. To support other aspiring pharmacists, like Joseph, please follow @PharmGradWishList on twitter and instagram and check out pharmgradwishlist.org!  Learn more about your ad choices. Visit megaphone.fm/adchoices

For thirty-five years, George S. Zorich worked as a pharmaceutical executive. Along the way, he served on several pharmacy boards, including the ASHP and that of the University of Wisconsin School of Pharmacy. He always found it surprising that graduates were very skilled at clinical pharmacy but not entrepreneurship. His book Entrepreneurs in Pharmacy and Other Leaders will become a useful text for pharmacy students and faculty alike under the new ACPE mandate that pharmacy programs teach entrepreneurship. Section one of the book profiles ten professionals who launched their own innovative businesses from a pharmacy degree. Section two highlights thirty people who became leaders in health care with their pharmacy degrees. Zorich is donating all of the royalties to pharmacy programs and foundations that encourage and foster entrepreneurship. Learn more about your ad choices. Visit megaphone.fm/adchoices

According to the Department of Health and Human Services: Fifty-five percent of the elderly are non-compliant with their prescription drug orders, meaning they don't take their medication according to the doctor's instructions. Approximately 200,000 older adults are hospitalized annually due to adverse drug reactions. Special guest:  Senior Care Pharmacy Coalition (SCPC) President and CEO Alan Rosenbloom  Washington, DC – Today, House Committee on Oversight and Reform Ranking Member James Comer (R-Ky.) and minority committee members lawmakers will hold a forum to discuss the impact of pharmacy benefit managers (PBMs) in pharmaceutical markets with industry experts, pharmacists, physicians, and PBMs. In anticipation of the forum the Senior Care Pharmacy Coalition (SCPC) offered the following statement from SCPC President and CEO Alan Rosenbloom: “We welcome today’s forum to examine PBMs and their anti-competitive practices, which ultimately drive-up costs for patients and put independent pharmacies out of business. A handful of PBMs dominate the market, and most are part of much larger health care conglomerates that spread both horizontally and vertically to encompass prescription drug plans and health insurers, retail, specialty, mail order, and long-term care (LTC) pharmacies, giving them immense power to favor the pharmacies they own over the pharmacies they don’t. This forces some pharmacies, especially LTC pharmacies, to provide life-saving medications to patients at a cost that could put them out of business and threaten patient access to essential medications, particularly in rural and medically underserved communities. Older Americans with long-term care needs require an average of 12-14 prescriptions per year. They are particularly vulnerable to soaring drug prices, and often least able to adapt when local pharmacies close. This is especially true of Medicare beneficiaries who need long-term care and typically have chronic or medically complex conditions as well. This group requires the medication management and enhanced pharmacy services that LTC pharmacies provide. Any unfair PBM practices that inhibit LTC pharmacy services or force them to close can be life-threatening for the hundreds of thousands of patients they serve daily. Today is a great first step and we thank Rep. James Comer (R-KY) for holding this important forum. Future inquiries must be bipartisan, and since LTC pharmacies and their patients are uniquely impacted by PBMs, we urge Congress to include LTC pharmacies in policy conversations like this one. Congress must pass legislation that requires transparency in PBM drug pricing and related information and provides stronger oversight to hold PBMs accountable.” Learn more about your ad choices. Visit megaphone.fm/adchoices

The contents of the super-soldier serum have been the subject of speculation for decades. Today we learn the truth about what makes Captain America great from our very own Justin Frederick.  This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane, Mickey, Cal and Justin are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health. A special thanks to Kelly Kerr for creating the music used in the intro and outro. Additional Music from Pixabay and Fesliyan Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

Today’s guest, Peter Koshland, PharmD, opened his compounding pharmacy, Koshland Pharm, in 2009 in San Francisco and works with doctors and patients on individualized, integrative therapies that make a difference in the quality of patients’ day-to-day lives. Peter has seen the profound impact high-quality compounded medicine can have, so producing the absolute best patient outcomes is what drives his decisions as CEO of Koshland Pharm. When he is not in the pharmacy, Peter spends his time consulting with and educating doctors about the multiple applications of compounded medicine in their respective fields. Interview topics:  Compounding for hormone replacement, dermatology, urology, thyroid disorders, and pain management  Why big pharma is lobbying against bio-identical HRT  How bias against compounding pharmacies could limit the options available to doctors treating patients  The economic impact that FDA overreach could have on pharmacists across the country  The importance of custom tailoring hormone treatments instead of using a “one size fits all” approach Learn more about your ad choices. Visit megaphone.fm/adchoices

In today’s episode, we welcome Jerry Meece, who is a major leader in diabetes management with nearly 25 years of experience. We discuss how diabetes education has evolved from a knowledge-based approach to a patient empowerment-based approach. Jerry also discussed the 10 minute consult that he created and how that can be implemented in your DSMES practice. He provides encouraging advice about how pharmacists can become more involved in diabetes management at a higher level.   References: PSAD Special Issue PaperTrends in diabetes self-management education https://onlinelibrary.wiley.com/doi/epdf/10.1111/dme.14256 Diabetes Self Management Education Patient Empowerment Learn more about your ad choices. Visit megaphone.fm/adchoices